Skip to main content
NIH funding notice RFA-DA-24-032

Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required)

Closed on May 23, 2025.

Posted
September 29, 2023
Close date
May 23, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $674,709 in first-year total cost, median $674,709.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 IXR-N (J2)]1

Most frequent institutions

  1. UNIVERSITY OF MISSOURI-COLUMBIA1
Competing awards under RFA-DA-24-032 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Neural Mechanisms underlying dissociable effects of cTBS in Psychostimulant Abuse1R01DA063122-01FROELIGER, BRETTUNIVERSITY OF MISSOURI-COLUMBIA, MO$674,709ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.